Nxera Pharma Co., Ltd. SOLTF
Set alert
8.50 USD 0.00 0.00%
At close · Oct 30
8.50 Day range 8.50
4.90 52-week range 8.50
- YTD
- +55.11%
- 1 year
- +38.44%
- Open
- 8.50
- Prev close
- 8.50
- Mkt cap
- 776.69M
- Vol
- 100
- Avg vol
- 85
- EPS
- -0.40
- P/E
- 0.00
More statistics
- Low
- 8.50
- High
- 8.50
2Y chart
Signals (78)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 23, 2026 | 1 week ago |
| RSI: Overbought | Oct 21, 2026 | 1 week ago |
| MACD: Sell Signal | Sep 29, 2026 | 1 month ago |
| SMA: Bullish | Sep 3, 2026 | 1 month ago |
| SMA: Bullish | Sep 3, 2026 | 1 month ago |
| RSI: Overbought | Sep 3, 2026 | 1 month ago |
| MACD: Buy Signal | Aug 21, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 6, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 3, 2026 | 3 months ago |
| SMA: Bearish | Jul 22, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 22, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 20, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 2, 2026 | 4 months ago |
| RSI: Oversold | Jul 2, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 26, 2026 | 4 months ago |
| SMA: Bearish | Jun 5, 2026 | 4 months ago |
| MACD: Sell Signal | May 29, 2026 | 5 months ago |
| MACD: Buy Signal | May 20, 2026 | 5 months ago |
| MACD: Sell Signal | May 12, 2026 | 5 months ago |
| RSI: Overbought | Apr 30, 2026 | 6 months ago |
| SMA: Bullish | Apr 16, 2026 | 6 months ago |
| SMA: Bullish | Apr 16, 2026 | 6 months ago |
| RSI: Overbought | Apr 16, 2026 | 6 months ago |
| MACD: Buy Signal | Apr 13, 2026 | 6 months ago |
| SMA: Bearish | Mar 23, 2026 | 7 months ago |
| RSI: Oversold | Mar 23, 2026 | 7 months ago |
| MACD: Sell Signal | Feb 27, 2026 | 8 months ago |
| MACD: Buy Signal | Feb 2, 2026 | 9 months ago |
| SMA: Bullish | Jan 29, 2026 | 9 months ago |
| MACD: Sell Signal | Jan 21, 2026 | 9 months ago |
| SMA: Bearish | Jan 20, 2026 | 9 months ago |
| SMA: Bullish | Jan 13, 2026 | 9 months ago |
| SMA: Bearish | Jan 9, 2026 | 9 months ago |
| MACD: Buy Signal | Dec 29, 2025 | 10 months ago |
| MACD: Sell Signal | Dec 26, 2025 | 10 months ago |
| MACD: Buy Signal | Dec 9, 2025 | 10 months ago |
| MACD: Sell Signal | Dec 3, 2025 | 11 months ago |
| MACD: Buy Signal | Nov 18, 2025 | 11 months ago |
| MACD: Sell Signal | Nov 4, 2025 | 12 months ago |
| RSI: Oversold | Nov 4, 2025 | 12 months ago |
| MACD: Buy Signal | Oct 29, 2025 | 1 year ago |
| SMA: Bearish | Oct 13, 2025 | 1 year ago |
| SMA: Bullish | Oct 2, 2025 | 1 year ago |
| SMA: Bearish | Sep 26, 2025 | 1 year ago |
| MACD: Sell Signal | Sep 26, 2025 | 1 year ago |
| SMA: Bullish | Sep 8, 2025 | 1 year ago |
| SMA: Bullish | Sep 8, 2025 | 1 year ago |
| MACD: Buy Signal | Sep 8, 2025 | 1 year ago |
| SMA: Bullish | Sep 3, 2025 | 1 year ago |
| MACD: Sell Signal | Aug 27, 2025 | 1 year ago |
| SMA: Bearish | Aug 26, 2025 | 1 year ago |
| SMA: Bearish | Aug 25, 2025 | 1 year ago |
| SMA: Bullish | Aug 22, 2025 | 1 year ago |
| SMA: Bullish | Aug 22, 2025 | 1 year ago |
| SMA: Bearish | Aug 21, 2025 | 1 year ago |
| SMA: Bearish | Aug 21, 2025 | 1 year ago |
| SMA: Bullish | Aug 18, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 18, 2025 | 1 year ago |
| MACD: Sell Signal | Aug 14, 2025 | 1 year ago |
| SMA: Bearish | Aug 13, 2025 | 1 year ago |
| SMA: Bullish | Aug 11, 2025 | 1 year ago |
| SMA: Bearish | Jul 30, 2025 | 1 year ago |
| SMA: Bullish | Jul 28, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 28, 2025 | 1 year ago |
| RSI: Oversold | Jul 16, 2025 | 1 year ago |
| SMA: Bearish | Jul 10, 2025 | 1 year ago |
| SMA: Bullish | Jun 26, 2025 | 1 year ago |
| SMA: Bearish | Jun 24, 2025 | 1 year ago |
| MACD: Sell Signal | Jun 24, 2025 | 1 year ago |
| RSI: Oversold | Jun 24, 2025 | 1 year ago |
| RSI: Overbought | Jun 4, 2025 | 1 year ago |
| MACD: Buy Signal | Jun 2, 2025 | 1 year ago |
| MACD: Sell Signal | May 27, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 8, 2025 | 1 year ago |
| MACD: Sell Signal | Mar 20, 2025 | 1 year ago |
| RSI: Oversold | Mar 20, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 6, 2025 | 1 year ago |
| RSI: Oversold | Dec 11, 2024 | 1 year ago |
News
- Nxera Pharma Co., Ltd. (SOLTF) Q3 2026 Earnings Call Transcript
- Nxera Pharma Co., Ltd. (SOLTF) Q2 2026 Earnings Call Transcript
- Nxera Joins OpenFold AI Research Consortium Alongside Leading Global Pharmaceutical and AI Companies to Accelerate AI-enabled Drug Discovery
- Nxera's Vamorolone Granted Key Regulatory Designations Supporting Faster Access for Duchenne Muscular Dystrophy Patients in South Korea
- Nxera's President & CEO to Participate in a ‘Fireside Chat' at the Jefferies New York Healthcare Conference 2026
- Nxera Pharma Announces Progress of Out-Licensing of GPCR-targeted Program and Participation in Series A Financing
- Nxera Files Patent Infringement Action in Relation to its miniG Platform Technology
- Nxera Pharma to Receive US$10 Million Milestone Payment from AbbVie under Collaboration Targeting Neurological Diseases
- Nxera Pharma Co., Ltd. (OTCMKTS:SOLTF) Short Interest Update
- Nxera Pharma's QUVIVIQ® (daridorexant) 25mg and 50mg Receives Approval in Taiwan for the Treatment of Insomnia
Your note
Sign in to keep a note on SOLTF — it syncs with the Stock Master app.